Product Code: RA100385
GLOBAL AT HOME TESTING KITS MARKET: OVERVIEW
As per Roots Analysis, the global at home testing kits market is estimated to grow from USD 14.8 billion in the current year to USD 31.15 billion by 2035, at a CAGR of 6% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Test Format
- Strip
- Stick
- Cassette
- Others
Type of Biofluid Analyzed
Therapeutic Area
- Fertility and Reproductive Health
- Metabolic Disorders
- Infectious Diseases
- Oncological Disorders
Area of Application
- Diagnostics
- Research
- Therapeutics
- Other Areas of Applications
Key Geographical Regions
- North America (US, Canada and Rest of North America)
- Europe (UK, Germany, France, Italy, Spain and Rest of Europe)
- Asia Pacific (India, China, Japan, South Korea, Indonesia and Rest of Asia-Pacific)
- Africa (Nigeria, Ethiopia, Egypt and Rest of Africa)
- South America (Argentina, Brazil and Rest of South America)
GLOBAL AT HOME TESTING KITS MARKET: GROWTH AND TRENDS
In the healthcare industry, digitization has evolved over time with numerous advancements, ensuring equitable access to novel health products and medical devices. Self- testing kits can improve health equity and accelerate progress towards universal health coverage, and it has the ability to improve health care. Self-testing kits provide individuals and communities with simple, quick, and private means to diagnose and treat a wide range of diseases, including HIV, hepatitis C, COVID-19, and, most recently, syphilis. People can now direct their own illness screening and make decisions based on their results safely, effectively, securely, and conveniently owing to more accessible and affordable self-tests and the expanding self-care movement.

Owing to several advantages offered by at-home self-testing kits for diagnostics and screening purposes, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such kits to provide healthcare at a fraction of a cost to the general public when compared to traditional clinics. Associated cost saving and privacy are main drivers of the growth of this domain over the coming decade. Currently, more than 650 at-home self-testing kits are available worldwide and are approved by regulatory authorities. The market is highly fragmented, featuring the presence of both new entrants and established players, based in different geographical regions.
GLOBAL AT HOME TESTING KITS MARKET: KEY INSIGHTS
The report delves into the current state of global at home testing kits market and identifies potential growth opportunities within industry. Some key findings from the report include:
- Over 510 at-home self-test kits have been developed for the screening, monitoring and diagnosis of a myriad of diseases, including diabetes, colon cancer and HIV.
- Majority of the at-home self-testing strips are primarily being used for monitoring diabetes and have received approval from regulatory authorities, such as the USFDA, ISO and IVD.

- Presently, more than 51% of the total at-home self-testing kit developers are based in North America.
- It is worth noting that most of the at-home self-testing kits are currently being used for monitoring disorders (43%), followed by those employed for detection of conditions related to fertility and reproductive health (22%).
- Most of the kits are being developed to follow invasive route for the procurement of analyte (56%), followed by those being manufactured to utilize non-invasive methods for procuring analyte (43%).
- More than 1,130 academic grants have been awarded to industry players to support the ongoing efforts related to research and innovation of at-home self-testing kits, over the past few years.
- Several non-profit organizations have extended financial support to aid the research related to at-home self-testing kits. It is worth mentioning that NIAID emerged as the most prominent non-profit organization, having awarded over 23% of grants for a period of 1-5 years, followed by NHLBI (12%).
- In order to gain competitive edge, firms continue to improve and benchmark their existing capabilities and capacities to offer a number of at-home self-testing solutions.
- Cost is a key determinant of the acceptance and adoption of assay kits; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings.
- Due to competitive pricing of products and rapid innovation being led by companies in this market, there are various lucrative opportunities for long term investments, with high possibility of positive return on investments.
- The current capacity is adequate to satisfy global annual demand; however, we expect that industry players will continue to invest in additional capacity to address long-term growth and rising future demand.
- It is worth highlighting that the demand for HIV screening kits is expected to grow at a rate of 13%. Further, the highest demand for such products is expected to be generated by the Asia-Pacific region in 2035 (56%).
- In the long-term, the overall projected opportunity is likely to be segregated across various therapeutic areas, biofluids analyzed, test formats and key geographical regions.

- The current market is driven by kits developed for metabolic disorders (64%); this trend is unlikely to change in the foreseen future as well. Further, based on type of test format, strip-based tests are likely to have the maximum revenue generation potential (50%), by 2035.
Example Players in the At Home Testing Kits Market
- ACON Laboratories,
- AdvaCare Pharma USA
- Apex Biotechnology
- i-SENS
- Oak Tree Health
- TaiDoc Technology
- VivaCheck Laboratories
GLOBAL At Home Testing Kits Market: RESEARCH COVERAGE
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global antiviral drugs market, focusing on key market segments, including [A] type of test format, [B] type of biofluid analyzed, [C] therapeutic area, [D] area of application and [E] key geographical regions.
- Market Landscape: A comprehensive evaluation of companies engaged in the development of at-home self-testing kits, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of testing procedure, [E] type of test format, [F] purpose of testing, [G] target therapeutic area, [H] wearability, [I] analyte procurement method, [J] biofluid analyzed, [K] processing time, [L] kit components, [M] regulatory approvals / certifications, [N] kit reusability, [O] availability of data management tools, [P] target analyte detected and [P] follow-up consultation requirement.
- Grant Analysis: An in-depth analysis of academic grants that have been awarded to various research institutes for conducting research focused on at-home self-testing kits, based on various relevant parameters, such as [A] year of grant award, [B] amount awarded, [C] support period, [D] type of funding institute center, [E] grant application, [F] purpose of grant award, [G] grant activity code, [H] NIH spending category, [I] study section involved, [J] popular NIH departments, [K] recipient organization, [L] regional distribution of recipient organization.
- Company Competitiveness Analysis: A comprehensive competitive analysis of at-home self-testing kit manufacturers, examining factors, such as [A] overall experience of the company, [B] product portfolio strength and [C] portfolio diversity.
- Company Profiles: In-depth profiles of companies engaged in offering at-home self-testing kits, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
- Bowman Clock Pricing Strategy: A comprehensive assessment to understand the pricing strategy of the at home self-testing kits offered by a firm, along with its competitive position in the market.
- Company Comparable Analysis: An in-depth analysis of company's intrinsic value by using comparable company analysis of publicly listed companies based on various parameters, such as [A] their current share price, [B] equity value, [C] enterprise value, [D] EBITDA, [E] net income and [F] revenue.
- Demand Analysis: A comprehensive analysis of annual demand for at-home self-testing kits, across various therapeutic areas, such as [A]] fertility and reproductive health, [B] metabolic disorders, [C] infectious diseases and [D] oncological disorders.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
- 1.1. Scope of the Report
- 1.2. Research Methodology
- 1.2.1. Research Assumptions
- 1.2.2. Project Methodology
- 1.2.3. Forecast Methodology
- 1.2.4. Robust Quality Control
- 1.2.5. Key Considerations
- 1.2.5.1. Demographics
- 1.2.5.2. Economic Factors
- 1.2.5.3. Government Regulations
- 1.2.5.4. Supply Chain
- 1.2.5.5. COVID Impact / Related Factors
- 1.2.5.6. Market Access
- 1.2.5.7. Healthcare Policies
- 1.2.5.8. Industry Consolidation
- 1.3 Key Questions Answered
- 1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
- 3.1. Chapter Overview
- 3.2. Introduction to At-Home Self-Testing
- 3.3. Types of At-home Tests
- 3.4. Types of At-home Test Assays
- 3.5. Advantages and Disadvantages Associated with At-home Self-testing Kits
- 3.6. Regulations Established for At-home Self-testing Kits
- 3.7. Future Perspective
4. MARKET OVERVIEW
- 4.1. Chapter Overview
- 4.2. At-home Self-testing Kits: List of Developers
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Company Size and Location of Headquarters
- 4.3. At-home Self-testing Kits: Overall Market Landscape
- 4.3.1. Analysis by Type of Testing Procedure
- 4.3.2. Analysis by Type of Test Format
- 4.3.3. Analysis by Purpose of Testing
- 4.3.4. Analysis by Target Therapeutic Area
- 4.3.5. Analysis by Kit Components
- 4.3.6. Analysis by Kit Wearability
- 4.3.7. Analysis by Target Analyte Detected
- 4.3.8. Analysis by Type of Analyte Procurement Method
- 4.3.9. Analysis by Type of Biofluid Analyzed
- 4.3.10. Analysis by Processing Time
- 4.3.11. Analysis by Number of Regulatory Approvals
- 4.3.12. Analysis by Kit Reusability
- 4.3.13. Analysis by Availability of Data Management Tools
- 4.3.14. Analysis by Follow-up Consultation Requirement
5. GRANTS ANALYSIS
- 5.1. Chapter Overview
- 5.2. Scope and Methodology
- 5.3. At-home Self-testing Kits: Grant Analysis
- 5.3.1. Analysis by Year of Grant Award
- 5.3.2. Analysis by Amount Awarded
- 5.3.3. Analysis by Support Period
- 5.3.4. Analysis by Support Period and Funding Institute Center
- 5.3.5. Analysis by Type of Grant Application
- 5.3.6. Analysis by Purpose of Grant Award
- 5.3.7. Analysis by Activity Code
- 5.3.8. Analysis by NIH Spending Categories (Word Cloud Representation)
- 5.3.9. Analysis by Study Section Involved
- 5.3.10. Popular NIH Departments: Analysis by Number of Grants
- 5.3.11. Analysis by Type of Recipient Organization
- 5.3.12. Prominent Program Officers: Analysis by Number of Grants
- 5.3.13. Popular Recipient Organizations: Analysis by Number of Grants
- 5.3.14. Popular Recipient Organizations: Analysis by Amount Awarded
- 5.3.15. Analysis by Region of Recipient Organization
6. COMPANY COMPETITIVENESS ANALYSIS
- 6.1. Chapter Overview
- 6.2. Key Assumptions and Parameters
- 6.3. Methodology
- 6.4. At-home Self-testing Kit Developers: Company Competitiveness Analysis
- 6.4.1. At-home Self-testing Kits Developers Based in North America
- 6.4.2. At-home Self-testing Kits Developers Based in Europe
- 6.4.3. At-home Self-testing Kits Developers Based in Asia-Pacific and Rest of the World
- 6.4.4. At-home Self-testing Kits Developers: Competitive Benchmarking
7. COMPANY PROFILES
- 7.1. Chapter Overview
- 7.2. ACON Laboratories
- 7.2.1. Company Overview
- 7.2.2. Product Portfolio
- 7.2.3. Recent Developments and Future Outlook
- 7.3. AdvaCare Pharma USA
- 7.3.1. Company Overview
- 7.3.2. Product Portfolio
- 7.3.3. Recent Developments and Future Outlook
- 7.4. Apex Biotechnology
- 7.4.1. Company Overview
- 7.4.2. Product Portfolio
- 7.4.3. Recent Developments and Future Outlook
- 7.5. i-SENS
- 7.5.1. Company Overview
- 7.5.2. Financial Information
- 7.5.3. Product Portfolio
- 7.5.4. Recent Developments and Future Outlook
- 7.6. Oak Tree Health
- 7.6.1. Company Overview
- 7.6.2. Product Portfolio
- 7.6.3. Recent Developments and Future Outlook
- 7.7. TaiDoc Technology
- 7.7.1. Company Overview
- 7.7.2. Product Portfolio
- 7.7.3. Recent Developments and Future Outlook
- 7.8. VivaCheck Laboratories
- 7.8.1. Company Overview
- 7.8.2. Product Portfolio
- 7.8.3. Recent Developments and Future Outlook
8. BOWMAN CLOCK PRICING STRATEGY
- 8.1. Chapter Overview
- 8.2. Bowman Strategy Clock
- 8.2.1. Two Dimensions of Bowman Strategy Clock
- 8.2.2. Eight Positions on Bowman Strategy Clock
- 8.3. Roots Analysis Framework
- 8.3.1. Methodology
- 8.3.2. Theoretical Framework and Price Evaluation Hypothesis
- 8.3.3. Results and Interpretation
- 8.3.3.1. Product Price Evaluation Matrix: Information on Type of Diagnostic Assay
- 8.3.3.2. Product Price Evaluation Matrix: Information on Temperature
- 8.3.3.3. Product Price Evaluation Matrix: Information on Purpose of Testing
- 8.3.3.4. Product Price Evaluation Matrix: Information on Type of Target Analyte
- 8.3.3.5. Product Price Evaluation Matrix: Information on Type of Test Format
- 8.4. Concluding Remarks
9. COMPANY COMPARABLE ANALYSIS
- 9.1. Chapter Overview
- 9.2. Scope and Methodology
- 9.3. Operating Statistics for Comparable Companies
- 9.3.1. Operating Statistics: Abbott Laboratories
- 9.3.2. Operating Statistics: Roche
- 9.3.3. Operating Statistics: Johnson & Johnson
- 9.3.4. Operating Statistics: Median, 25th And 75th Percentile Multiple
- 9.4. Valuation Statistics for Comparable Companies
- 9.4.1. Valuation Statistics: Abbott Laboratories
- 9.4.2. Valuation Statistics: Roche
- 9.4.3. Valuation Statistics: Johnson & Johnson
- 9.4.4. Valuation Statistics: Median, 25th And 75th Percentile Multiple
- 9.5. Valuation Summary for Abbott Laboratories
- 9.5.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.5.2. Football Field Analysis: Abbott Laboratories
- 9.6. Valuation Summary for Roche
- 9.6.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.6.2. Football Field Analysis: Roche
- 9.7. Valuation Summary for Johnson & Johnson
- 9.7.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.7.2. Football Field Analysis: Johnson & Johnson
10. DEMAND ANALYSIS
- 10.1. Chapter Overview
- 10.2. Scope and Methodology
- 10.3. Global Demand for At-home Self-testing Kits
- 10.4. Demand for At-home Self-testing Kits: Analysis by Geography
- 10.5. Demand for At-home Self-testing Kits: Analysis by Therapeutic Area
- 10.5.1. Demand for At-home Self-testing Fertility and Reproductive Health Kits
- 10.5.1.1. Demand for At-home Self-testing Pregnancy Test Kits
- 10.5.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in North America
- 10.5.1.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in the US
- 10.5.1.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Canada
- 10.5.1.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of North America
- 10.5.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Europe
- 10.5.1.1.2.1. Demand for At-home Self-testing Pregnancy Test Kits in the UK
- 10.5.1.1.2.2. Demand for At-home Self-testing Pregnancy Test Kits in Germany
- 10.5.1.1.2.3. Demand for At-home Self-testing Pregnancy Test Kits in Spain
- 10.5.1.1.2.4. Demand for At-home Self-testing Pregnancy Test Kits in Italy
- 10.5.1.1.2.5. Demand for At-home Self-testing Pregnancy Test Kits in France
- 10.5.1.1.2.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Europe
- 10.5.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Asia-Pacific
- 10.5.1.1.3.1. Demand for At-home Self-testing Pregnancy Test Kits in India
- 10.5.1.1.3.2. Demand for At-home Self-testing Pregnancy Test Kits in China
- 10.5.1.1.3.3. Demand for At-home Self-testing Pregnancy Test Kits in Japan
- 10.5.1.1.3.4. Demand for At-home Self-testing Pregnancy Test Kits in South Korea
- 10.5.1.1.3.5. Demand for At-home Self-testing Pregnancy Test Kits in Indonesia
- 10.5.1.1.3.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Asia-Pacific
- 10.5.1.1.4. Demand for At-home Self-testing Pregnancy Test Kits in Africa
- 10.5.1.1.4.1. Demand for At-home Self-testing Pregnancy Test Kits in Nigeria
- 10.5.1.1.4.2. Demand for At-home Self-testing Pregnancy Test Kits in Ethiopia
- 10.5.1.1.4.3. Demand for At-home Self-testing Pregnancy Test Kits in Egypt
- 10.5.1.1.4.4. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Africa
- 10.5.1.1.5. Demand for At-home Self-testing Pregnancy Test Kits in South America
- 10.5.1.1.5.1. Demand for At-home Self-testing Pregnancy Test Kits in Argentina
- 10.5.1.1.5.2. Demand for At-home Self-testing Pregnancy Test Kits in Brazil
- 10.5.1.1.5.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of South America
- 10.5.1.2. Demand for At-home Self-testing Ovulation Test Kits
- 10.5.1.2.1. Demand for At-home Self-testing Ovulation Test Kits in North America
- 10.5.1.2.1.1. Demand for At-home Self-testing Ovulation Test Kits in the US
- 10.5.1.2.1.2. Demand for At-home Self-testing Ovulation Test Kits in Canada
- 10.5.1.2.1.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of North America
- 10.5.1.2.2. Demand for At-home Self-testing Ovulation Test Kits in Europe
- 10.5.1.2.2.1. Demand for At-home Self-testing Ovulation Test Kits in the UK
- 10.5.1.2.2.2. Demand for At-home Self-testing Ovulation Test Kits in Germany
- 10.5.1.2.2.3. Demand for At-home Self-testing Ovulation Test Kits in Spain
- 10.5.1.2.2.4. Demand for At-home Self-testing Ovulation Test Kits in Italy
- 10.5.1.2.2.5. Demand for At-home Self-testing Ovulation Test Kits in France
- 10.5.1.2.2.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Europe
- 10.5.1.2.3. Demand for At-home Self-testing Ovulation Test Kits in Asia-Pacific
- 10.5.1.2.3.1. Demand for At-home Self-testing Ovulation Test Kits in India
- 10.5.1.2.3.2. Demand for At-home Self-testing Ovulation Test Kits in China
- 10.5.1.2.3.3. Demand for At-home Self-testing Ovulation Test Kits in Japan
- 10.5.1.2.3.4. Demand for At-home Self-testing Ovulation Test Kits in South Korea
- 10.5.1.2.3.5. Demand for At-home Self-testing Ovulation Test Kits in Indonesia
- 10.5.1.2.3.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Asia-Pacific
- 10.5.1.2.4. Demand for At-home Self-testing Ovulation Test Kits in Africa
- 10.5.1.2.4.1. Demand for At-home Self-testing Ovulation Test Kits in Nigeria
- 10.5.1.2.4.2. Demand for At-home Self-testing Ovulation Test Kits in Ethiopia
- 10.5.1.2.4.3. Demand for At-home Self-testing Ovulation Test Kits in Egypt
- 10.5.1.2.4.4. Demand for At-home Self-testing Ovulation Test Kits in Rest of Africa
- 10.5.1.2.5. Demand for At-home Self-testing Ovulation Test Kits in South America
- 10.5.1.2.5.1. Demand for At-home Self-testing Ovulation Test Kits in Argentina
- 10.5.1.2.5.2. Demand for At-home Self-testing Ovulation Test Kits in Brazil
- 10.5.1.2.5.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of South America
- 10.5.2. Demand for At-home Self-testing Infectious Diseases Kits
- 10.5.2.1. Demand for At-home Self-testing HIV Test Kits
- 10.5.2.1.1. Demand for At-home Self-testing HIV Test Kits in North America
- 10.5.2.1.1.1. Demand for At-home Self-testing HIV Test Kits in the US
- 10.5.2.1.1.2. Demand for At-home Self-testing HIV Test Kits in Canada
- 10.5.2.1.1.3. Demand for At-home Self-testing HIV Test Kits in Rest of North America
- 10.5.2.1.2. Demand for At-home Self-testing HIV Test Kits in Europe
- 10.5.2.1.2.1. Demand for At-home Self-testing HIV Test Kits in the UK
- 10.5.2.1.2.2. Demand for At-home Self-testing HIV Test Kits in Germany
- 10.5.2.1.2.3. Demand for At-home Self-testing HIV Test Kits in Spain
- 10.5.2.1.2.4. Demand for At-home Self-testing HIV Test Kits in Italy
- 10.5.2.1.2.5. Demand for At-home Self-testing HIV Test Kits in France
- 10.5.2.1.2.6. Demand for At-home Self-testing HIV Test Kits in Rest of Europe
- 10.5.2.1.3. Demand for At-home Self-testing HIV Test Kits in Asia-Pacific
- 10.5.2.1.3.1. Demand for At-home Self-testing HIV Test Kits in India
- 10.5.2.1.3.2. Demand for At-home Self-testing HIV Test Kits in China
- 10.5.2.1.3.3. Demand for At-home Self-testing HIV Test Kits in Japan
- 10.5.2.1.3.4. Demand for At-home Self-testing HIV Test Kits in South Korea
- 10.5.2.1.3.5. Demand for At-home Self-testing HIV Test Kits in Indonesia
- 10.5.2.1.3.6. Demand for At-home Self-testing HIV Test Kits in Rest of Asia-Pacific
- 10.5.2.1.4. Demand for At-home Self-testing HIV Test Kits in Africa
- 10.5.2.1.4.1. Demand for At-home Self-testing HIV Test Kits in Nigeria
- 10.5.2.1.4.2. Demand for At-home Self-testing HIV Test Kits in Ethiopia
- 10.5.2.1.4.3. Demand for At-home Self-testing HIV Test Kits in Egypt
- 10.5.2.1.4.4. Demand for At-home Self-testing HIV Test Kits in Rest of Africa
- 10.5.2.1.5. Demand for At-home Self-testing HIV Test Kits in South America
- 10.5.2.1.5.1. Demand for At-home Self-testing HIV Test Kits in Argentina
- 10.5.2.1.5.2. Demand for At-home Self-testing HIV Test Kits in Brazil
- 10.5.2.1.5.3. Demand for At-home Self-testing HIV Test Kits in Rest of South America
- 10.5.3. Demand for At-home Self-testing Metabolic Disorders Kits
- 10.5.3.1. Demand for At-home Self-testing Diabetes Test Kits
- 10.5.3.1.1. Demand for At-home Self-testing Diabetes Test Kits in North America
- 10.5.3.1.1.1. Demand for At-home Self-testing Diabetes Test Kits in the US
- 10.5.3.1.1.2. Demand for At-home Self-testing Diabetes Test Kits in Canada
- 10.5.3.1.1.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of North America
- 10.5.3.1.2. Demand for At-home Self-testing Diabetes Test Kits in Europe
- 10.5.3.1.2.1. Demand for At-home Self-testing Diabetes Test Kits in the UK
- 10.5.3.1.2.2. Demand for At-home Self-testing Diabetes Test Kits in Germany
- 10.5.3.1.2.3. Demand for At-home Self-testing Diabetes Test Kits in Spain
- 10.5.3.1.2.4. Demand for At-home Self-testing Diabetes Test Kits in Italy
- 10.5.3.1.2.5. Demand for At-home Self-testing Diabetes Test Kits in France
- 10.5.3.1.2.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Europe
- 10.5.3.1.3. Demand for At-home Self-testing Diabetes Test Kits in Asia-Pacific
- 10.5.3.1.3.1. Demand for At-home Self-testing Diabetes Test Kits in India
- 10.5.3.1.3.2. Demand for At-home Self-testing Diabetes Test Kits in China
- 10.5.3.1.3.3. Demand for At-home Self-testing Diabetes Test Kits in Japan
- 10.5.3.1.3.4. Demand for At-home Self-testing Diabetes Test Kits in South Korea
- 10.5.3.1.3.5. Demand for At-home Self-testing Diabetes Test Kits in Indonesia
- 10.5.3.1.3.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Asia-Pacific
- 10.5.3.1.4. Demand for At-home Self-testing Diabetes Test Kits in Africa
- 10.5.3.1.4.1. Demand for At-home Self-testing Diabetes Test Kits in Nigeria
- 10.5.3.1.4.2. Demand for At-home Self-testing Diabetes Test Kits in Ethiopia
- 10.5.3.1.4.3. Demand for At-home Self-testing Diabetes Test Kits in Egypt
- 10.5.3.1.4.4. Demand for At-home Self-testing Diabetes Test Kits in Rest of Africa
- 10.5.3.1.5. Demand for At-home Self-testing Diabetes Test Kits in South America
- 10.5.3.1.5.1. Demand for At-home Self-testing Diabetes Test Kits in Argentina
- 10.5.3.1.5.2. Demand for At-home Self-testing Diabetes Test Kits in Brazil
- 10.5.3.1.5.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of South America
- 10.5.4. Demand for At-home Self-testing Oncological Disorders Kits
- 10.5.4.1. Demand for At-home Self-testing Colon Cancer Test Kits
- 10.5.4.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in North America
- 10.5.4.1.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in the US
- 10.5.4.1.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Canada
- 10.5.4.1.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of North America
- 10.5.4.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Europe
- 10.5.4.1.2.1. Demand for At-home Self-testing Colon Cancer Test Kits in the UK
- 10.5.4.1.2.2. Demand for At-home Self-testing Colon Cancer Test Kits in Germany
- 10.5.4.1.2.3. Demand for At-home Self-testing Colon Cancer Test Kits in Spain
- 10.5.4.1.2.4. Demand for At-home Self-testing Colon Cancer Test Kits in Italy
- 10.5.4.1.2.5. Demand for At-home Self-testing Colon Cancer Test Kits in France
- 10.5.4.1.2.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Europe
- 10.5.4.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Asia-Pacific
- 10.5.4.1.3.1. Demand for At-home Self-testing Colon Cancer Test Kits in India
- 10.5.4.1.3.2. Demand for At-home Self-testing Colon Cancer Test Kits in China
- 10.5.4.1.3.3. Demand for At-home Self-testing Colon Cancer Test Kits in Japan
- 10.5.4.1.3.4. Demand for At-home Self-testing Colon Cancer Test Kits in South Korea
- 10.5.4.1.3.5. Demand for At-home Self-testing Colon Cancer Test Kits in Indonesia
- 10.5.4.1.3.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Asia-Pacific
- 10.5.4.1.4. Demand for At-home Self-testing Colon Cancer Test Kits in Africa
- 10.5.4.1.4.1. Demand for At-home Self-testing Colon Cancer Test Kits in Nigeria
- 10.5.4.1.4.2. Demand for At-home Self-testing Colon Cancer Test Kits in Ethiopia
- 10.5.4.1.4.3. Demand for At-home Self-testing Colon Cancer Test Kits in Egypt
- 10.5.4.1.4.4. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Africa
- 10.5.4.1.5. Demand for At-home Self-testing Colon Cancer Test Kits in South America
- 10.5.4.1.5.1. Demand for At-home Self-testing Colon Cancer Test Kits in Argentina
- 10.5.4.1.5.2. Demand for At-home Self-testing Colon Cancer Test Kits in Brazil
- 10.5.4.1.5.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of South America
- 10.6. Concluding Remarks
11. MARKET FORECAST AND OPPUTUNITY ANALYSIS
- 11.1. Chapter Overview
- 11.2. Scope and Methodology
- 11.3. Global At-home Self-testing Kits Market, Till 2035
- 11.4. At-home Self-testing Kits Market: Analysis by Geography
- 11.5. At-home Self-testing Kits Market: Analysis by Therapeutic Area, Till 2035
- 11.5.1. At-home Self-testing Kits Market for Fertility and Reproductive Health, Till 2035
- 11.5.1.1. At-home Self-testing Kits Market for Pregnancy Detection, Till 2035
- 11.5.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in North America, Till 2035
- 11.5.1.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in the US, Till 2035
- 11.5.1.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Canada, Till 2035
- 11.5.1.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of North America, Till 2035
- 11.5.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Europe, Till 2035
- 11.5.1.1.2.1. At-home Self-testing Kits Market for Pregnancy Detection in the UK, Till 2035
- 11.5.1.1.2.2. At-home Self-testing Kits Market for Pregnancy Detection in Germany, Till 2035
- 11.5.1.1.2.3. At-home Self-testing Kits Market for Pregnancy Detection in Spain, Till 2035
- 11.5.1.1.2.4. At-home Self-testing Kits Market for Pregnancy Detection in Italy, Till 2035
- 11.5.1.1.2.5. At-home Self-testing Kits Market for Pregnancy Detection in France, Till 2035
- 11.5.1.1.2.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Europe, Till 2035
- 11.5.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Asia-Pacific, Till 2035
- 11.5.1.1.3.1. At-home Self-testing Kits Market for Pregnancy Detection in India, Till 2035
- 11.5.1.1.3.2. At-home Self-testing Kits Market for Pregnancy Detection in China, Till 2035
- 11.5.1.1.3.3. At-home Self-testing Kits Market for Pregnancy Detection in Japan, Till 2035
- 11.5.1.1.3.4. At-home Self-testing Kits Market for Pregnancy Detection in South Korea, Till 2035
- 11.5.1.1.3.5. At-home Self-testing Kits Market for Pregnancy Detection in Indonesia, Till 2035
- 11.5.1.1.3.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Asia-Pacific, Till 2035
- 11.5.1.1.4. At-home Self-testing Kits Market for Pregnancy Detection in Africa, Till 2035
- 11.5.1.1.4.1. At-home Self-testing Kits Market for Pregnancy Detection in Nigeria, Till 2035
- 11.5.1.1.4.2. At-home Self-testing Kits Market for Pregnancy Detection in Ethiopia, Till 2035
- 11.5.1.1.4.3. At-home Self-testing Kits Market for Pregnancy Detection in Egypt, Till 2035
- 11.5.1.1.4.4. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Africa, Till 2035
- 11.5.1.1.5. At-home Self-testing Kits Market for Pregnancy Detection in South America, Till 2035
- 11.5.1.1.5.1. At-home Self-testing Kits Market for Pregnancy Detection in Argentina, Till 2035
- 11.5.1.1.5.2. At-home Self-testing Kits Market for Pregnancy Detection in Brazil, Till 2035
- 11.5.1.1.5.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of South America, Till 2035
- 11.5.1.2. At-home Self-testing Kits Market for Ovulation Monitoring, Till 2035
- 11.5.1.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in North America, Till 2035
- 11.5.1.2.1.1. At-home Self-testing Kits Market for Ovulation Monitoring in the US, Till 2035
- 11.5.1.2.1.2. At-home Self-testing Kits Market for Ovulation Monitoring in Canada, Till 2035
- 11.5.1.2.1.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of North America, Till 2035
- 11.5.1.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Europe, Till 2035
- 11.5.1.2.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in the UK, Till 2035
- 11.5.1.2.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Germany, Till 2035
- 11.5.1.2.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Spain, Till 2035
- 11.5.1.2.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Italy, Till 2035
- 11.5.1.2.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in France, Till 2035
- 11.5.1.2.2.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Europe, Till 2035
- 11.5.1.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Asia-Pacific, Till 2035
- 11.5.1.2.3.1. At-home Self-testing Kits Market for Ovulation Monitoring in India, Till 2035
- 11.5.1.2.3.2. At-home Self-testing Kits Market for Ovulation Monitoring in China, Till 2035
- 11.5.1.2.3.3. At-home Self-testing Kits Market for Ovulation Monitoring in Japan, Till 2035
- 11.5.1.2.3.4. At-home Self-testing Kits Market for Ovulation Monitoring in South Korea, Till 2035
- 11.5.1.2.3.5. At-home Self-testing Kits Market for Ovulation Monitoring in Indonesia, Till 2035
- 11.5.1.2.3.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Asia-Pacific, Till 2035
- 11.5.1.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Africa, Till 2035
- 11.5.1.2.4.1. At-home Self-testing Kits Market for Ovulation Monitoring in Nigeria, Till 2035
- 11.5.1.2.4.2. At-home Self-testing Kits Market for Ovulation Monitoring in Ethiopia, Till 2035
- 11.5.1.2.4.3. At-home Self-testing Kits Market for Ovulation Monitoring in Egypt, Till 2035
- 11.5.1.2.4.4. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Africa, Till 2035
- 11.5.1.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in South America, Till 2035
- 11.5.1.2.5.1. At-home Self-testing Kits Market for Ovulation Monitoring in Argentina, Till 2035
- 11.5.1.2.5.2. At-home Self-testing Kits Market for Ovulation Monitoring in Brazil, Till 2035
- 11.5.1.2.5.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of South America, Till 2035
- 11.5.2. At-home Self-testing Kits Market for Infectious Diseases, Till 2035
- 11.5.2.1. At-home Self-testing Kits Market for HIV Detection, Till 2035
- 11.5.2.1.1. At-home Self-testing Kits Market for HIV Detection in North America, Till 2035
- 11.5.2.1.1.1. At-home Self-testing Kits Market for HIV Detection in the US, Till 2035
- 11.5.2.1.1.2. At-home Self-testing Kits Market for HIV Detection in Canada, Till 2035
- 11.5.2.1.1.3. At-home Self-testing Kits Market for HIV Detection in Rest of North America, Till 2035
- 11.5.2.1.2. At-home Self-testing Kits Market for HIV Detection in Europe, Till 2035
- 11.5.2.1.2.1. At-home Self-testing Kits Market for HIV Detection in the UK, Till 2035
- 11.5.2.1.2.2. At-home Self-testing Kits Market for HIV Detection in Germany, Till 2035
- 11.5.2.1.2.3. At-home Self-testing Kits Market for HIV Detection in Spain, Till 2035
- 11.5.2.1.2.4. At-home Self-testing Kits Market for HIV Detection in Italy, Till 2035
- 11.5.2.1.2.5. At-home Self-testing Kits Market for HIV Detection in France, Till 2035
- 11.5.2.1.2.6. At-home Self-testing Kits Market for HIV Detection in Rest of Europe, Till 2035
- 11.5.2.1.3. At-home Self-testing Kits Market for HIV Detection in Asia-Pacific, Till 2035
- 11.5.2.1.3.1. At-home Self-testing Kits Market for HIV Detection in India, Till 2035
- 11.5.2.1.3.2. At-home Self-testing Kits Market for HIV Detection in China, Till 2035
- 11.5.2.1.3.3. At-home Self-testing Kits Market for HIV Detection in Japan, Till 2035
- 11.5.2.1.3.4. At-home Self-testing Kits Market for HIV Detection in South Korea, Till 2035
- 11.5.2.1.3.5. At-home Self-testing Kits Market for HIV Detection in Indonesia, Till 2035
- 11.5.2.1.3.6. At-home Self-testing Kits Market for HIV Detection in Rest of Asia-Pacific, Till 2035
- 11.5.2.1.4. At-home Self-testing Kits Market for HIV Detection in Africa, Till 2035
- 11.5.2.1.4.1. At-home Self-testing Kits Market for HIV Detection in Nigeria, Till 2035
- 11.5.2.1.4.2. At-home Self-testing Kits Market for HIV Detection in Ethiopia, Till 2035
- 11.5.2.1.4.3. At-home Self-testing Kits Market for HIV Detection in Egypt, Till 2035
- 11.5.2.1.4.4. At-home Self-testing Kits Market for HIV Detection in Rest of Africa, Till 2035
- 11.5.2.1.5. At-home Self-testing Kits Market for HIV Detection in South America, Till 2035
- 11.5.2.1.5.1. At-home Self-testing Kits Market for HIV Detection in Argentina, Till 2035
- 11.5.2.1.5.2. At-home Self-testing Kits Market for HIV Detection in Brazil, Till 2035
- 11.5.2.1.5.3. At-home Self-testing Kits Market for HIV Detection in Rest of South America, Till 2035
- 11.5.3. At-home Self-testing Kits Market for Metabolic Disorders, Till 2035
- 11.5.3.1. At-home Self-testing Kits Market for Diabetes Monitoring, Till 2035
- 11.5.3.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in North America, Till 2035
- 11.5.3.1.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in the US, Till 2035
- 11.5.3.1.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Canada, Till 2035
- 11.5.3.1.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of North America, Till 2035
- 11.5.3.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Europe, Till 2035
- 11.5.3.1.2.1. At-home Self-testing Kits Market for Diabetes Monitoring in the UK, Till 2035
- 11.5.3.1.2.2. At-home Self-testing Kits Market for Diabetes Monitoring in Germany, Till 2035
- 11.5.3.1.2.3. At-home Self-testing Kits Market for Diabetes Monitoring in Spain, Till 2035
- 11.5.3.1.2.4. At-home Self-testing Kits Market for Diabetes Monitoring in Italy, Till 2035
- 11.5.3.1.2.5. At-home Self-testing Kits Market for Diabetes Monitoring in France, Till 2035
- 11.5.3.1.2.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Europe, Till 2035
- 11.5.3.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Asia-Pacific, Till 2035
- 11.5.3.1.3.1. At-home Self-testing Kits Market for Diabetes Monitoring in India, Till 2035
- 11.5.3.1.3.2. At-home Self-testing Kits Market for Diabetes Monitoring in China, Till 2035
- 11.5.3.1.3.3. At-home Self-testing Kits Market for Diabetes Monitoring in Japan, Till 2035
- 11.5.3.1.3.4. At-home Self-testing Kits Market for Diabetes Monitoring in South Korea, Till 2035
- 11.5.3.1.3.5. At-home Self-testing Kits Market for Diabetes Monitoring in Indonesia, Till 2035
- 11.5.3.1.3.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Asia-Pacific, Till 2035
- 11.5.3.1.4. At-home Self-testing Kits Market for Diabetes Monitoring in Africa, Till 2035
- 11.5.3.1.4.1. At-home Self-testing Kits Market for Diabetes Monitoring in Nigeria, Till 2035
- 11.5.3.1.4.2. At-home Self-testing Kits Market for Diabetes Monitoring in Ethiopia, Till 2035
- 11.5.3.1.4.3. At-home Self-testing Kits Market for Diabetes Monitoring in Egypt, Till 2035
- 11.5.3.1.4.4. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Africa, Till 2035
- 11.5.3.1.5. At-home Self-testing Kits Market for Diabetes Monitoring in South America, Till 2035
- 11.5.3.1.5.1. At-home Self-testing Kits Market for Diabetes Monitoring in Argentina, Till 2035
- 11.5.3.1.5.2. At-home Self-testing Kits Market for Diabetes Monitoring in Brazil, Till 2035
- 11.5.3.1.5.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of South America, Till 2035
- 11.5.4. At-home Self-testing Kits Market for Oncological Disorders, Till 2035
- 11.5.4.1. At-home Self-testing Kits Market for Colon Cancer Detection, Till 2035
- 11.5.4.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in North America, Till 2035
- 11.5.4.1.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in the US, Till 2035
- 11.5.4.1.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Canada, Till 2035
- 11.5.4.1.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of North America, Till 2035
- 11.5.4.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Europe, Till 2035
- 11.5.4.1.2.1. At-home Self-testing Kits Market for Colon Cancer Detection in the UK, Till 2035
- 11.5.4.1.2.2. At-home Self-testing Kits Market for Colon Cancer Detection in Germany, Till 2035
- 11.5.4.1.2.3. At-home Self-testing Kits Market for Colon Cancer Detection in Spain, Till 2035
- 11.5.4.1.2.4. At-home Self-testing Kits Market for Colon Cancer Detection in Italy, Till 2035
- 11.5.4.1.2.5. At-home Self-testing Kits Market for Colon Cancer Detection in France, Till 2035
- 11.5.4.1.2.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Europe, Till 2035
- 11.5.4.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Asia-Pacific, Till 2035
- 11.5.4.1.3.1. At-home Self-testing Kits Market for Colon Cancer Detection in India, Till 2035
- 11.5.4.1.3.2. At-home Self-testing Kits Market for Colon Cancer Detection in China, Till 2035
- 11.5.4.1.3.3. At-home Self-testing Kits Market for Colon Cancer Detection in Japan, Till 2035
- 11.5.4.1.3.4. At-home Self-testing Kits Market for Colon Cancer Detection in South Korea, Till 2035
- 11.5.4.1.3.5. At-home Self-testing Kits Market for Colon Cancer Detection in Indonesia, Till 2035
- 11.5.4.1.3.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Asia-Pacific, Till 2035
- 11.5.4.1.4. At-home Self-testing Kits Market for Colon Cancer Detection in Africa, Till 2035
- 11.5.4.1.4.1. At-home Self-testing Kits Market for Colon Cancer Detection in Nigeria, Till 2035
- 11.5.4.1.4.2. At-home Self-testing Kits Market for Colon Cancer Detection in Ethiopia, Till 2035
- 11.5.4.1.4.3. At-home Self-testing Kits Market for Colon Cancer Detection in Egypt, Till 2035
- 11.5.4.1.4.4. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Africa, Till 2035
- 11.5.4.1.5. At-home Self-testing Kits Market for Colon Cancer Detection in South America, Till 2035
- 11.5.4.1.5.1. At-home Self-testing Kits Market for Colon Cancer Detection in Argentina, Till 2035
- 11.5.4.1.5.2. At-home Self-testing Kits Market for Colon Cancer Detection in Brazil, Till 2035
- 11.5.4.1.5.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of South America
- 11.6. At-home Self-testing Kits Market: Analysis by Type of Test Format, Till 2035
- 11.6.1. At-home Self-testing Kits Market for Stick based Tests, Till 2035
- 11.6.2. At-home Self-testing Kits Market for Strip based Tests, Till 2035
- 11.6.3. At-home Self-testing Kits Market for Cassette based Tests, Till 2035
- 11.6.4. At-home Self-testing Kits Market for Other Formats, Till 2035
- 11.7. At-home Self-testing Kits Market: Analysis by Type of Biofluid Analyzed, Till 2035
- 11.7.1. At-home Self-testing Kits Market for Urine based Tests, Till 2035
- 11.7.2. At-home Self-testing Kits Market for Blood based Tests, Till 2035
- 11.7.3. At-home Self-testing Kits Market for Stool based Tests, Till 2035
12. ATTRACTIVENESS COMPETETIVENESS MATRIX
- 12.1. Chapter Overview
- 12.2. AC Matrix: An Overview
- 12.2.1. Strong Business Segments
- 12.2.2. Average Business Segments
- 12.2.3. Weak Business Segments
- 12.3. Analytical Methodology
- 12.4. AC Matrix: Overall At-home Self-testing Kits Market Scenario
- 12.4.1. AC Matrix: Overall At-home Self-testing Kits Market Scenario for Target Therapeutic Area
- 12.4.2. AC Matrix: Overall At-home Self-testing Kits Market Scenario for Regions
13. CONCLUDING REMARKS
14. INTERVIEW TRANSCRIPTS
- 14.1. Chapter Overview
- 14.2. Company A
- 14.2.1. Company Snapshot
- 14.2.2. Interview Transcript, Vice President, Sales, and Marketing
- 14.3. Company B
- 14.3.1. Company Snapshot
- 14.3.2. Interview Transcript, Associate Vice President
15. APPENDIX I: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS